2025-14619Notice

Drug Discounts Pilot: Hospitals Apply for Rebate Model

Published Date: 8/1/2025

Notice

Summary

The 340B Rebate Model Pilot Program is a new, optional way for drug makers to help covered health providers get better drug prices. This program affects drug manufacturers and health centers that serve patients in need, aiming to keep medicine affordable. The application process is open now, and feedback is welcome, with possible updates coming later.

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Voluntary 340B Rebate Pilot Available Now

HHS/HRSA has opened a voluntary 340B Rebate Model Pilot Program that lets qualifying drug manufacturers apply to provide 340B ceiling prices on select drugs to covered entities (health centers). The application process is open now, HRSA is collecting public comments on the program and application, and the Notice is effective immediately as published.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
8/1/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Health Resources and Services Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register